Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer

• Published in: Frontiers in immunology Vol. 15; p. 1293618
• Main Authors: Zhu, Hehuan, Roelands, Jessica, Ahmed, Eiman I, Stouten, Imke, Hoorntje, Rachel, van Vlierberghe, Ronald L P, Ijsselsteijn, Marieke E, Lei, Xin, de Miranda, Noel F C C, Tollenaar, Rob A E M, Vahrmeijer, Alexander L, Bedognetti, Davide, Hendrickx, Wouter R L, Kuppen, Peter J K
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 05.02.2024
• Subjects: colon cancer; immunologic constant of rejection; Immunology; multiplex immunofluorescence; spatial analysis; T cell; tumor microenvironment; immunologic constant of rejection; spatial analysis; tumor microenvironment; T cell; colon cancer; multiplex immunofluorescence
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2024.1293618

Colon cancer is a heterogeneous disease and consists of various molecular subtypes. Despite advances in high-throughput expression profiling, limitations remain in predicting clinical outcome and assigning specific treatment to individual cases. Tumor-immune interactions play a critical role, with tumors that activate the immune system having better outcome for the patient. The localization of T cells within tumor epithelium, to enable direct contact, is essential for antitumor function, but bulk DNA/RNA sequencing data lacks spatial distribution information. In this study, we provide spatial T cell tumor distribution and connect these data with previously determined genomic data in the AC-ICAM colon cancer patient cohort. Colon cancer patients (n=90) with transcriptome data available were selected. We used a custom multiplex immunofluorescence assay on colon tumor tissue sections for quantifying T cell subsets spatial distribution in the tumor microenvironment, in terms of cell number, location, mutual distance, and distance to tumor cells. Statistical analyses included the previously determined Immunologic Constant of Rejection (ICR) transcriptome correlation and patient survival, revealing potential prognostic value in T cell spatial distribution. T cell phenotypes were characterized and CD3 CD8 FoxP3 T cells were found to be the predominant tumor-infiltrating subtype while CD3 FoxP3 T cells and CD3 CD8 T cells showed similar densities. Spatial distribution analysis elucidated that proliferative T cells, characterized by Ki67 expression, and Granzyme B-expressing T cells were predominantly located within the tumor epithelium. We demonstrated an increase in immune cell density and a decrease in the distance of CD3 CD8 T cells to the nearest tumor cell, in the immune active, ICR High, immune subtypes. Higher densities of stromal CD3 FoxP3 T cells showed enhanced survival outcomes, and patients exhibited superior clinical benefits when greater spatial distances were observed between CD3 CD8 FoxP3 or CD3 CD8 T cells and CD3 FoxP3 T cells. Our study's in-depth analysis of the spatial distribution and densities of major T cell subtypes within the tumor microenvironment has provided valuable information that paves the way for further research into the intricate relationships between immune cells and colon cancer development.